Back to All NewsCandela Announces Health Canada Approval of New Gynecological Indications for CO2RE Laser Platform
Posted By American Med Spa Association, Thursday, June 18, 2020
Share
Candela Corporation, a leading global aesthetic device company, has announced that Health Canada has approved the CO2RE laser, the world's first fully integrated CO2 workstation, for the treatment of genitourinary syndrome of menopause (GSM) and stress urinary incontinence (SUI) in adult women.
The CO2RE laser, a single CO2 platform equipped with six treatment modes and multiple customized handpieces, is indicated for use in 10 medical specialties, including dermatology, aesthetics and gynecology. The CO2RE laser with Intima handpiece and module provides practitioners a simple and efficient gynecological solution for the treatment of the introitus, vaginal canal and external genitalia.
The CO2RE laser, a single CO2 platform equipped with six treatment modes and multiple customized handpieces, is indicated for use in 10 medical specialties, including dermatology, aesthetics and gynecology. The CO2RE laser with Intima handpiece and module provides practitioners a simple and efficient gynecological solution for the treatment of the introitus, vaginal canal and external genitalia.
